06 Feb2014
Posted in News, World
Australia-based Bionomics’ phase I clinical trial of ovarian cancerdrug candidate BNC105 received positive results. The market for drugs to treat ovarian cancer is valued at over $2 billion per annum
06 Feb2014
Posted in News, World
Repaglinide tablets are the generic equivalent of Novo Nordisk’s Prandin tablets and is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Contact Us
Do you have any queries?
